If you liked this article you might like

Valeant and Teva Share Similar Ambitions With Similar Pitfalls

Valeant Isn't Out of Trouble Yet, Debt Remains Difficult to Curb

Marriott, Holiday Inn Dip As On-Demand Economy Claims Next Victim -ICYMI Tues.

Valeant Pops on Earnings Beat, Debt Reduction Effort

Biotech Movers: FibroGen Leaps on Results for Pulmonary Fibrosis Study